XML 70 R62.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award      
Stock-based compensation expense recognized $ 6,108 $ 4,817 $ 4,394
Unrecognized Compensation Cost $ 3,096    
Expiration date of 2007 Stock Incentive Plan May 20, 2024    
Outstanding:      
Stock options exercised (in shares)     77,334
Restricted Stock Units [Member]      
Share-based Compensation Arrangement by Share-based Payment Award      
Stock-based compensation expense recognized $ 5,931 $ 4,603 $ 4,231
Unrecognized Compensation Cost $ 3,096    
Weighted Average Remaining Amortization Periods 9 months 18 days    
Number of units [Abstract]      
Balance (in shares) 904,000 986,000 1,004,000
Granted (in shares) 314,000 252,000 304,000
Vested (in shares) [1] (361,000) (334,000) (322,000)
Cancelled or forfeited (in shares) (15,000) 0 0
Balance (in shares) 842,000 904,000 986,000
Expected to vest (in shares) 842,000 904,000 986,000
Weighted Average Grant-date Fair Value per Unit [Abstract]      
Beginning balance, Weighted average grant-date fair value (in dollars per share) $ 14.77 $ 13.34 $ 12.74
Granted, Weighted average grant-date fair value (in dollars per share) 19.85 18.90 15.52
Vested, Weighted average grant-date fair value (in dollars per share) [1] 11.70 13.67 13.54
Cancelled or forfeited, Weighted average grant date fair value (in dollars per share) 17.71 0 0
Ending balance, Weighted average grant-date fair value (in dollars per share) $ 17.93 $ 14.77 $ 13.34
Phantom Stock Units [Member]      
Share-based Compensation Arrangement by Share-based Payment Award      
Stock-based compensation expense recognized $ 177 $ 214 $ 163
Unrecognized Compensation Cost $ 0    
Weighted Average Remaining Amortization Periods 0 years    
Number of units [Abstract]      
Balance (in shares) 170,000 157,000 145,000
Granted (in shares) 10,000 10,000 10,000
Dividend equivalents issued (in shares) 3,000 3,000 2,000
Balance (in shares) 183,000 170,000 157,000
Weighted Average Grant-date Fair Value per Unit [Abstract]      
Granted, Weighted average grant-date fair value (in dollars per share) $ 17.72 $ 21.35 $ 16.25
Performance Vested Restricted Stock Units [Member] | Scheduled to Vest January 1, 2020 [Member]      
Number of units [Abstract]      
Balance (in shares) [2] 167,000    
Expected to vest (in shares) [2] 167,000    
Not expected to vest (in shares) [2] 0    
Performance Vested Restricted Stock Units [Member] | Scheduled to Vest January 1, 2021 [Member]      
Number of units [Abstract]      
Balance (in shares) 141,000    
Expected to vest (in shares) 141,000    
Not expected to vest (in shares) 0    
Performance Vested Restricted Stock Units [Member] | Scheduled to Vest January 1, 2022 [Member]      
Number of units [Abstract]      
Balance (in shares) 174,000    
Expected to vest (in shares) 174,000    
Not expected to vest (in shares) 0    
2007 Stock Incentive Plan [Member]      
Share-based Compensation Arrangement by Share-based Payment Award      
Maximum number of shares authorized under restricted stock, unrestricted stock, RSU's and stock options to officers, employees and non-employee directors (in shares) 6,500,000    
Exercisable (in shares)      
Available for future grants (in shares) 2,580,000    
[1] The number of RSUs vested includes shares that the Company withheld on behalf of employees to satisfy statutory tax withholding requirements.
[2] The performance vesting criteria for the performance-based RSUs with a vesting date of January 1, 2020 were achieved.